Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00064636
Status:
TERMINATED
Last Update Posted:
2005-06-24
First Post:
2003-07-10
Brief Title:
Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Sponsor:
Organization:
Millennium Pharmaceuticals Inc